An update on the advancements in the treatment of agitation in Alzheimer’s disease-Reference-Cited by-同舟云学术

An update on the advancements in the treatment of agitation in Alzheimer’s disease

Published:2017-03-28 Issue:6 Volume:18 Page:611-620
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Porsteinsson Anton P.¹,Antonsdottir Inga M.²

Affiliation:

1. Alzheimer’s Disease Care, Research and Education Program (AD-CARE), Department of Psychiatry, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA

2. Department of Psychiatry and Behavioral Sciences, Division of Geriatric Psychiatry and Neuropsychiatry, Johns Hopkins University School of Medicine, Baltimore, MD, USA

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2017.1307340

Reference38 articles.

1. Behavioural changes and psychological symptoms in dementia disorders

2. Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study

3. Course of neuropsychiatric symptoms during a 4-year follow up in the REAL-FR cohort

4. Management of Neuropsychiatric Symptoms of Dementia in Clinical Settings: Recommendations from a Multidisciplinary Expert Panel

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of selective serotonin reuptake inhibitors-related antidepressants in Alzheimer’s disease: a meta-analysis;European Journal of Medical Research;2024-08-29

2. Memantine: Updating a rare success story in pro-cognitive therapeutics;Neuropharmacology;2024-02

3. Improved Pharmacokinetic and Pharmacodynamic Profile of Deuterium-Reinforced Tricyclic Antidepressants Doxepin, Dosulepin, and Clomipramine in Animal Models;European Journal of Drug Metabolism and Pharmacokinetics;2024-01-03

4. Neuropsychiatric Symptoms (NPS) and Neurocognitive Disorders;Age-Adjusted Psychiatric Treatment for the Older Patient;2024

5. A real-world assessment of healthcare costs associated with agitation in Alzheimer’s dementia;Journal of Medical Economics;2023-12-26